Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.
about
MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerDiagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocolApoptomiRs of Breast Cancer: Basics to ClinicsMicroRNAs in the pathobiology of sarcomasLong non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagyAn ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of gliomaMicroRNAome genome: a treasure for cancer diagnosis and therapy.Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis.A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patientsMicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsThe predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis.Angiomirs expression profiling in diffuse large B-Cell lymphoma.Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer.Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts.Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcoma.The role of hypoxia-induced miR-210 in cancer progression.MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.Noncoding RNAs in Cancer Diagnosis.MiR-210 links hypoxia with cell proliferation regulation in human Laryngocarcinoma cancer.MicroRNA-148a represents an independent prognostic marker in bladder cancer.Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) study.MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents.The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer.Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma.
P2860
Q26777313-1DB58DDB-C884-4C1E-9FF4-56A7F3ED3D9CQ28071747-A8092D68-7FC3-4A65-8FD2-02E73CF87810Q28072414-356B7FA2-B327-4274-A62D-7AB3378666A5Q28085250-0456777E-7F07-4E03-855A-2BBFA4BC1A9FQ33761792-311FE48E-723B-4D6C-B888-DA94EB26A652Q34514808-6FBE7E1B-D90B-4ACB-8C4A-90F78EB48CD3Q35094742-7DFEF337-BD86-46B7-91C4-00E3597C63C8Q35103188-31B70311-EF11-4FCE-8E95-354A038D818DQ35112630-ACEBDA4C-9E5E-4C4F-94D4-E828AA6CD1B8Q35275041-08AC27AE-6424-4D68-8791-FD64BD88273DQ35704188-B4FBF6C1-62C1-48DF-8EDB-31D9AADEF383Q35710429-30517BCF-0F50-40AD-B7F0-F64DB7D7CF93Q35740150-9099EC63-C027-4F7D-921B-19A3506C0521Q35955244-ABC75B7A-4780-4478-94F3-B02D2106C927Q36111707-56A6626B-2350-4042-983F-A18B758DEF3FQ36782590-094FA4BA-5BF5-47E3-8D1D-37038F6A1986Q37203114-55497463-9509-4179-9023-19E486C777FDQ37269137-1F8F8A78-9E19-4592-AAE6-4E7E32174087Q38379679-463AE4AD-C634-476A-A76A-A2FF758F67BFQ38391282-1CAC6329-45FD-475E-AB48-6FA9C791F97BQ38550157-F6BA327E-21D8-4707-AB73-8BE0EB42CE12Q38885507-A57B602F-CF55-4EBD-B0F3-0EFDBD8570C9Q38914407-D69BE19A-5A74-413B-A42A-5FE42A5E9BDDQ41024564-084E7C9F-13F3-4D7A-B9FF-CB0E080F5A6BQ41991354-8E4F4517-67BE-414B-8964-5B5B3B82E868Q47037323-BDD0D2A7-3F46-4261-A62E-93BED3D966E1Q47149216-8B76B8FB-FE63-4793-B2FB-EC43A5E556E2Q50732901-44722220-C35A-4107-A5CB-C9C6AE125050Q55011586-E45FF364-EA5D-4D13-B0C4-DA181D9B2567Q55360157-924B7D49-BFD5-4020-B204-24938B02691E
P2860
Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Elevated expression of miR-210 ...... atic review and meta-analysis.
@ast
Elevated expression of miR-210 ...... atic review and meta-analysis.
@en
type
label
Elevated expression of miR-210 ...... atic review and meta-analysis.
@ast
Elevated expression of miR-210 ...... atic review and meta-analysis.
@en
prefLabel
Elevated expression of miR-210 ...... atic review and meta-analysis.
@ast
Elevated expression of miR-210 ...... atic review and meta-analysis.
@en
P2093
P2860
P31
P1433
P1476
Elevated expression of miR-210 ...... atic review and meta-analysis.
@en
P2093
Fahuan Yuan
Huiqin Sun
Jiqing Zhao
Mengjing Shi
Zhongmin Zou
P2860
P304
P356
10.1371/JOURNAL.PONE.0089223
P407
P5008
P577
2014-02-20T00:00:00Z